These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15582744)

  • 1. Molecular misreading: the frequency of dinucleotide deletions in neuronal mRNAs for beta-amyloid precursor protein and ubiquitin B.
    Gerez L; de Haan A; Hol EM; Fischer DF; van Leeuwen FW; van Steeg H; Benne R
    Neurobiol Aging; 2005 Feb; 26(2):145-55. PubMed ID: 15582744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The novel cytosolic RING finger protein dactylidin is up-regulated in brains of patients with Alzheimer's disease.
    von Rotz RC; Kins S; Hipfel R; von der Kammer H; Nitsch RM
    Eur J Neurosci; 2005 Mar; 21(5):1289-98. PubMed ID: 15813938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of APP pathway mRNAs and proteins in Alzheimer's disease.
    Matsui T; Ingelsson M; Fukumoto H; Ramasamy K; Kowa H; Frosch MP; Irizarry MC; Hyman BT
    Brain Res; 2007 Aug; 1161():116-23. PubMed ID: 17586478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decoy mRNAs reduce beta-amyloid precursor protein mRNA in neuronal cells.
    Westmark PR; Shin HC; Westmark CJ; Soltaninassab SR; Reinke EK; Malter JS
    Neurobiol Aging; 2006 Jun; 27(6):787-96. PubMed ID: 16672170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid precursor protein mRNA levels in Alzheimer's disease brain.
    Preece P; Virley DJ; Costandi M; Coombes R; Moss SJ; Mudge AW; Jazin E; Cairns NJ
    Brain Res Mol Brain Res; 2004 Mar; 122(1):1-9. PubMed ID: 14992810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rac1 inhibition negatively regulates transcriptional activity of the amyloid precursor protein gene.
    Wang PL; Niidome T; Akaike A; Kihara T; Sugimoto H
    J Neurosci Res; 2009 Jul; 87(9):2105-14. PubMed ID: 19267423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frameshift proteins in autosomal dominant forms of Alzheimer disease and other tauopathies.
    van Leeuwen FW; van Tijn P; Sonnemans MA; Hobo B; Mann DM; Van Broeckhoven C; Kumar-Singh S; Cras P; Leuba G; Savioz A; Maat-Schieman ML; Yamaguchi H; Kros JM; Kamphorst W; Hol EM; de Vos RA; Fischer DF
    Neurology; 2006 Jan; 66(2 Suppl 1):S86-92. PubMed ID: 16432153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Distribution of amyloid precursor protein mRNA in Alzheimer brain tissues].
    Mori M; Yoshiyama Y; Waragai M; Yoshikawa K; Yamada T
    No To Shinkei; 1997 Sep; 49(9):804-8. PubMed ID: 9310996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease.
    Mohmmad Abdul H; Sultana R; Keller JN; St Clair DK; Markesbery WR; Butterfield DA
    J Neurochem; 2006 Mar; 96(5):1322-35. PubMed ID: 16478525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular misreading. A new type of transcript mutation in gerontology.
    van Leeuwen FW; Fischer DF; Benne R; Hol EM
    Ann N Y Acad Sci; 2000 Jun; 908():267-81. PubMed ID: 10911966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human-like rodent amyloid-beta-peptide determines Alzheimer pathology in aged wild-type Octodon degu.
    Inestrosa NC; Reyes AE; Chacón MA; Cerpa W; Villalón A; Montiel J; Merabachvili G; Aldunate R; Bozinovic F; Aboitiz F
    Neurobiol Aging; 2005 Jul; 26(7):1023-8. PubMed ID: 15748782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of iron-regulated amyloid precursor protein and beta-amyloid peptide by (-)-epigallocatechin-3-gallate in cell cultures: implications for iron chelation in Alzheimer's disease.
    Reznichenko L; Amit T; Zheng H; Avramovich-Tirosh Y; Youdim MB; Weinreb O; Mandel S
    J Neurochem; 2006 Apr; 97(2):527-36. PubMed ID: 16539659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Swedish amyloid precursor protein mutation increases cell cycle-related proteins in vitro and in vivo.
    Ahn KW; Joo Y; Choi Y; Kim M; Lee SH; Cha SH; Suh YH; Kim HS
    J Neurosci Res; 2008 Aug; 86(11):2476-87. PubMed ID: 18438935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer's disease.
    Ryoo SR; Cho HJ; Lee HW; Jeong HK; Radnaabazar C; Kim YS; Kim MJ; Son MY; Seo H; Chung SH; Song WJ
    J Neurochem; 2008 Mar; 104(5):1333-44. PubMed ID: 18005339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid-beta precursor protein mediates neuronal toxicity of amyloid beta through Go protein activation.
    Sola Vigo F; Kedikian G; Heredia L; Heredia F; Añel AD; Rosa AL; Lorenzo A
    Neurobiol Aging; 2009 Sep; 30(9):1379-92. PubMed ID: 18187234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fermented papaya preparation attenuates beta-amyloid precursor protein: beta-amyloid-mediated copper neurotoxicity in beta-amyloid precursor protein and beta-amyloid precursor protein Swedish mutation overexpressing SH-SY5Y cells.
    Zhang J; Mori A; Chen Q; Zhao B
    Neuroscience; 2006 Nov; 143(1):63-72. PubMed ID: 16962711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the APP promoter in Alzheimer's disease: cell type-specific expression of the beta-amyloid precursor protein.
    Lahiri DK; Ge YW
    Ann N Y Acad Sci; 2004 Dec; 1030():310-6. PubMed ID: 15659812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretory form of Alzheimer amyloid precursor protein 695 in human brain lacks beta/A4 amyloid immunoreactivity.
    Kametani F; Tanaka K; Ishii T; Ikeda S; Kennedy HE; Allsop D
    Biochem Biophys Res Commun; 1993 Mar; 191(2):392-8. PubMed ID: 8460999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excess of nicastrin in brain results in heterozygosity having no effect on endogenous APP processing and amyloid peptide levels in vivo.
    Brijbassi S; Amtul Z; Newbigging S; Westaway D; St George-Hyslop P; Rozmahel RF
    Neurobiol Dis; 2007 Feb; 25(2):291-6. PubMed ID: 17071095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Proteins with frameshift mutations in Alzheimer's disease; cause or effect?].
    Scheper W; Gool WA
    Ned Tijdschr Geneeskd; 1998 May; 142(22):1244-7. PubMed ID: 9749295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.